This study investigates immune function in rapid cycling bipolar patients a
nd normal volunteers before and after 30 days of lithium treatment. Previou
s small studies in symptomatic bipolar patients suggested that nonspecific
immune activation might be present. While studies of the effects of lithium
on immune function found that lithium increased serum SIL-2RS in normal vo
lunteers and seemed to normalize immune function in bipolar patients. We hy
pothesized that the immune profile of rapid cycling bipolar patients would
also manifest immune activation that lithium treatment might normalize. The
more stable serum immune measures (SIL-2RS and SIL-6RS) were increased in
symptomatic rapid cycling patients and did normalize with lithium treatment
. Lithium treatment increased IL-2, SIL-2RS and SIL-6RS in normal volunteer
s. These data suggest that rapid cycling bipolar patients may have mild imm
une activation which seems to normalize with lithium treatment. (C) 1999 El
sevier Science Ltd. All rights reserved.